Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026
24/02/2026 09:06
Feb 24 (Reuters) - SynAct Pharma AB SYNACT.ST: APPOINTS ANN KRISTIN LED AS CFO EFFECTIVE MARCH 2026 Source text: ID:nMFNbMZL2R Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026